Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Sclerosis | 48 | 2024 | 3222 | 6.770 |
Why?
|
Immunologic Factors | 10 | 2024 | 1589 | 1.660 |
Why?
|
Pregnancy Complications | 11 | 2024 | 2948 | 1.610 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 5 | 2024 | 556 | 1.430 |
Why?
|
Clinical Trials, Phase III as Topic | 2 | 2018 | 857 | 0.920 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 2 | 2023 | 254 | 0.860 |
Why?
|
Spouse Abuse | 1 | 2022 | 182 | 0.740 |
Why?
|
Contraception | 3 | 2024 | 347 | 0.720 |
Why?
|
Interferon-beta | 2 | 2022 | 345 | 0.710 |
Why?
|
Neuromyelitis Optica | 2 | 2022 | 264 | 0.670 |
Why?
|
Pregnancy Outcome | 6 | 2024 | 2921 | 0.660 |
Why?
|
Leukemia, Plasma Cell | 1 | 2019 | 46 | 0.650 |
Why?
|
Pregnancy | 22 | 2024 | 29869 | 0.600 |
Why?
|
Abortion, Spontaneous | 2 | 2024 | 532 | 0.600 |
Why?
|
Menopause | 2 | 2017 | 1645 | 0.580 |
Why?
|
Milk, Human | 1 | 2022 | 486 | 0.570 |
Why?
|
Family Planning Services | 2 | 2023 | 266 | 0.570 |
Why?
|
Contraceptive Devices, Female | 1 | 2017 | 40 | 0.570 |
Why?
|
Postpartum Period | 3 | 2021 | 1178 | 0.550 |
Why?
|
Immunosuppressive Agents | 5 | 2023 | 4172 | 0.540 |
Why?
|
Polyethylene Glycols | 1 | 2022 | 1182 | 0.530 |
Why?
|
Disease Progression | 8 | 2020 | 13495 | 0.520 |
Why?
|
Contraceptive Agents, Female | 1 | 2017 | 118 | 0.510 |
Why?
|
Live Birth | 1 | 2018 | 510 | 0.480 |
Why?
|
Reproduction | 1 | 2019 | 646 | 0.470 |
Why?
|
Recurrence | 10 | 2023 | 8426 | 0.470 |
Why?
|
Gonadal Steroid Hormones | 1 | 2018 | 702 | 0.460 |
Why?
|
Disabled Persons | 1 | 2023 | 1226 | 0.450 |
Why?
|
Infertility | 1 | 2020 | 654 | 0.440 |
Why?
|
Estrogen Replacement Therapy | 2 | 2017 | 1208 | 0.440 |
Why?
|
Cognition Disorders | 4 | 2020 | 3979 | 0.430 |
Why?
|
Sex Characteristics | 3 | 2018 | 2637 | 0.410 |
Why?
|
Toluidines | 2 | 2024 | 21 | 0.410 |
Why?
|
Crotonates | 2 | 2024 | 21 | 0.410 |
Why?
|
Atrophy | 6 | 2018 | 1632 | 0.390 |
Why?
|
Disease Management | 2 | 2019 | 2506 | 0.360 |
Why?
|
Mothers | 2 | 2024 | 2194 | 0.350 |
Why?
|
Female | 55 | 2024 | 392203 | 0.340 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3680 | 0.280 |
Why?
|
Disability Evaluation | 7 | 2021 | 1835 | 0.270 |
Why?
|
Hydroxybutyrates | 2 | 2024 | 76 | 0.270 |
Why?
|
Magnetic Resonance Imaging | 21 | 2024 | 36401 | 0.260 |
Why?
|
Humans | 59 | 2024 | 760740 | 0.250 |
Why?
|
Retrospective Studies | 15 | 2024 | 80583 | 0.240 |
Why?
|
Adult | 33 | 2024 | 220995 | 0.220 |
Why?
|
Lymphocyte Depletion | 1 | 2024 | 601 | 0.200 |
Why?
|
Cerebral Cortex | 1 | 2018 | 5776 | 0.200 |
Why?
|
Demyelinating Diseases | 2 | 2024 | 352 | 0.200 |
Why?
|
Demyelinating Autoimmune Diseases, CNS | 1 | 2021 | 38 | 0.190 |
Why?
|
Nitriles | 2 | 2024 | 971 | 0.190 |
Why?
|
Thalamus | 1 | 2007 | 1047 | 0.180 |
Why?
|
Brain | 8 | 2019 | 27100 | 0.180 |
Why?
|
Schizophrenia, Paranoid | 1 | 2021 | 103 | 0.180 |
Why?
|
Middle Aged | 25 | 2024 | 220603 | 0.170 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 7390 | 0.170 |
Why?
|
Lactation | 1 | 2022 | 397 | 0.170 |
Why?
|
Birth Rate | 1 | 2020 | 168 | 0.160 |
Why?
|
Severity of Illness Index | 7 | 2021 | 15829 | 0.160 |
Why?
|
Brain Neoplasms | 2 | 2019 | 9026 | 0.160 |
Why?
|
Abortion, Therapeutic | 1 | 2018 | 35 | 0.160 |
Why?
|
Risperidone | 1 | 2021 | 381 | 0.160 |
Why?
|
Antirheumatic Agents | 2 | 2018 | 1365 | 0.160 |
Why?
|
Young Adult | 12 | 2024 | 59191 | 0.150 |
Why?
|
Puerperal Disorders | 1 | 2020 | 300 | 0.140 |
Why?
|
Sexual Dysfunction, Physiological | 2 | 2013 | 361 | 0.140 |
Why?
|
Registries | 3 | 2024 | 8209 | 0.140 |
Why?
|
Depression, Postpartum | 1 | 2021 | 349 | 0.140 |
Why?
|
Spinal Cord | 4 | 2014 | 1807 | 0.140 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 1997 | 140 | 0.130 |
Why?
|
Antibody Formation | 1 | 2021 | 1390 | 0.130 |
Why?
|
Acetates | 1 | 1997 | 321 | 0.130 |
Why?
|
Amines | 1 | 1997 | 281 | 0.130 |
Why?
|
Age Factors | 4 | 2018 | 18381 | 0.130 |
Why?
|
Anthropometry | 1 | 2020 | 1338 | 0.120 |
Why?
|
Vaccination | 3 | 2022 | 3370 | 0.120 |
Why?
|
Contraception Behavior | 1 | 2016 | 180 | 0.120 |
Why?
|
Pregnancy Trimester, First | 1 | 2018 | 908 | 0.120 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2011 | 951 | 0.110 |
Why?
|
Vaccines | 1 | 2022 | 838 | 0.110 |
Why?
|
Sample Size | 1 | 2017 | 838 | 0.110 |
Why?
|
Prevalence | 2 | 2022 | 15702 | 0.110 |
Why?
|
Male | 25 | 2024 | 360402 | 0.110 |
Why?
|
Steroids | 1 | 2018 | 928 | 0.110 |
Why?
|
Infant | 4 | 2024 | 36157 | 0.100 |
Why?
|
Cesarean Section, Repeat | 1 | 2012 | 28 | 0.100 |
Why?
|
Premature Birth | 1 | 2024 | 1782 | 0.100 |
Why?
|
gamma-Aminobutyric Acid | 1 | 1997 | 1140 | 0.090 |
Why?
|
B-Lymphocytes | 1 | 2024 | 4745 | 0.090 |
Why?
|
Analgesics | 1 | 1997 | 1067 | 0.090 |
Why?
|
Prospective Studies | 4 | 2024 | 54364 | 0.090 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2630 | 0.090 |
Why?
|
Anesthesia, Obstetrical | 1 | 2012 | 232 | 0.090 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2756 | 0.090 |
Why?
|
Cohort Studies | 3 | 2021 | 41464 | 0.080 |
Why?
|
HLA-B Antigens | 1 | 2010 | 317 | 0.080 |
Why?
|
Adolescent | 7 | 2020 | 88247 | 0.080 |
Why?
|
Incidence | 2 | 2024 | 21339 | 0.080 |
Why?
|
Biopsy | 2 | 2019 | 6763 | 0.080 |
Why?
|
Infant, Newborn | 3 | 2024 | 26183 | 0.070 |
Why?
|
Antipsychotic Agents | 1 | 2021 | 3067 | 0.070 |
Why?
|
Comorbidity | 2 | 2021 | 10507 | 0.070 |
Why?
|
Anticonvulsants | 1 | 1997 | 1910 | 0.070 |
Why?
|
Neuropsychological Tests | 4 | 2021 | 7050 | 0.070 |
Why?
|
Third Ventricle | 1 | 2007 | 74 | 0.070 |
Why?
|
United States | 3 | 2020 | 72292 | 0.070 |
Why?
|
Child | 4 | 2024 | 80089 | 0.070 |
Why?
|
Odds Ratio | 1 | 2018 | 9644 | 0.070 |
Why?
|
Insurance, Health | 1 | 2018 | 2495 | 0.070 |
Why?
|
Psychotic Disorders | 1 | 2021 | 3220 | 0.070 |
Why?
|
Spinal Cord Neoplasms | 1 | 2008 | 261 | 0.060 |
Why?
|
Ear Neoplasms | 1 | 2006 | 118 | 0.060 |
Why?
|
Anesthesia, General | 1 | 2012 | 1173 | 0.060 |
Why?
|
Ear Canal | 1 | 2006 | 147 | 0.060 |
Why?
|
Cognition | 2 | 2020 | 6988 | 0.060 |
Why?
|
Inflammation | 2 | 2021 | 10759 | 0.060 |
Why?
|
Breast Feeding | 1 | 2012 | 1355 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2018 | 8998 | 0.060 |
Why?
|
Genetic Counseling | 1 | 2007 | 627 | 0.060 |
Why?
|
Astrocytoma | 1 | 2008 | 774 | 0.050 |
Why?
|
Cytokines | 1 | 2018 | 7373 | 0.050 |
Why?
|
Databases, Factual | 1 | 2018 | 7963 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5334 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3088 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3209 | 0.050 |
Why?
|
Pain | 1 | 1997 | 5062 | 0.050 |
Why?
|
Phenotype | 1 | 2020 | 16572 | 0.050 |
Why?
|
Antigens, CD20 | 1 | 2022 | 199 | 0.050 |
Why?
|
Hospitalization | 1 | 2021 | 10708 | 0.050 |
Why?
|
Expert Testimony | 1 | 2024 | 364 | 0.050 |
Why?
|
Ovulation Induction | 1 | 2023 | 277 | 0.050 |
Why?
|
Peripartum Period | 1 | 2021 | 137 | 0.040 |
Why?
|
Delphi Technique | 1 | 2024 | 846 | 0.040 |
Why?
|
Theilovirus | 1 | 1999 | 11 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2011 | 3356 | 0.040 |
Why?
|
Cardiovirus Infections | 1 | 1999 | 20 | 0.040 |
Why?
|
Stroke | 1 | 2021 | 9715 | 0.040 |
Why?
|
New England | 1 | 2021 | 1050 | 0.040 |
Why?
|
Regression Analysis | 1 | 2007 | 6339 | 0.040 |
Why?
|
Aged | 5 | 2023 | 169092 | 0.040 |
Why?
|
Thiazoles | 1 | 2024 | 1517 | 0.030 |
Why?
|
Pain, Intractable | 1 | 1997 | 132 | 0.030 |
Why?
|
Prenatal Care | 1 | 2024 | 1140 | 0.030 |
Why?
|
Contraceptives, Oral, Combined | 1 | 2016 | 116 | 0.030 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2016 | 190 | 0.030 |
Why?
|
Fertilization in Vitro | 1 | 2023 | 1292 | 0.030 |
Why?
|
Statistics, Nonparametric | 2 | 2011 | 2851 | 0.030 |
Why?
|
Aging | 1 | 2013 | 8700 | 0.030 |
Why?
|
Consensus | 1 | 2024 | 3117 | 0.030 |
Why?
|
JC Virus | 1 | 2014 | 87 | 0.030 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 1999 | 823 | 0.030 |
Why?
|
Sex Factors | 1 | 2007 | 10549 | 0.030 |
Why?
|
Androstanols | 1 | 2012 | 45 | 0.030 |
Why?
|
Smoking | 1 | 2009 | 9054 | 0.030 |
Why?
|
Polyomavirus Infections | 1 | 2014 | 191 | 0.020 |
Why?
|
Neuromuscular Nondepolarizing Agents | 1 | 2012 | 143 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2007 | 15250 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3149 | 0.020 |
Why?
|
Methyl Ethers | 1 | 2012 | 196 | 0.020 |
Why?
|
Reference Values | 2 | 2009 | 4919 | 0.020 |
Why?
|
Glioblastoma | 1 | 2006 | 3481 | 0.020 |
Why?
|
HLA-C Antigens | 1 | 2010 | 140 | 0.020 |
Why?
|
HLA-A Antigens | 1 | 2010 | 223 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2012 | 15609 | 0.020 |
Why?
|
Mortality | 1 | 2021 | 2899 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2024 | 12333 | 0.020 |
Why?
|
Anesthetics, Intravenous | 1 | 2012 | 394 | 0.020 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2012 | 693 | 0.020 |
Why?
|
Fentanyl | 1 | 2012 | 433 | 0.020 |
Why?
|
Immunoglobulins | 1 | 2012 | 850 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2017 | 39062 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2010 | 17878 | 0.020 |
Why?
|
Algorithms | 1 | 2009 | 14024 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8619 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2014 | 2358 | 0.020 |
Why?
|
Anesthetics, Inhalation | 1 | 2012 | 572 | 0.020 |
Why?
|
DNA, Viral | 1 | 2014 | 2194 | 0.020 |
Why?
|
Brain Infarction | 1 | 2009 | 289 | 0.020 |
Why?
|
Laminectomy | 1 | 2008 | 225 | 0.020 |
Why?
|
Risk Factors | 3 | 2021 | 74128 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 3798 | 0.020 |
Why?
|
Animals | 2 | 2017 | 168202 | 0.020 |
Why?
|
Propofol | 1 | 2012 | 602 | 0.020 |
Why?
|
Time Factors | 2 | 2021 | 39908 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2021 | 12759 | 0.020 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2008 | 550 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2014 | 3145 | 0.020 |
Why?
|
Hearing Disorders | 1 | 2006 | 126 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2013 | 14599 | 0.020 |
Why?
|
HLA Antigens | 1 | 2010 | 1327 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2011 | 14649 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 3410 | 0.010 |
Why?
|
Neurologic Examination | 1 | 2007 | 915 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 2012 | 1878 | 0.010 |
Why?
|
Gene Frequency | 1 | 2010 | 3601 | 0.010 |
Why?
|
Bone Density | 1 | 2016 | 3548 | 0.010 |
Why?
|
Linear Models | 1 | 2013 | 5866 | 0.010 |
Why?
|
Decompression, Surgical | 1 | 2008 | 606 | 0.010 |
Why?
|
Neurofibromatosis 2 | 1 | 2006 | 383 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1999 | 9171 | 0.010 |
Why?
|
Depression | 1 | 2021 | 8132 | 0.010 |
Why?
|
Oxygen | 1 | 2012 | 4226 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2013 | 26065 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8652 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 10203 | 0.010 |
Why?
|
Radiography | 1 | 2010 | 6961 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2009 | 6473 | 0.010 |
Why?
|
Temporal Lobe | 1 | 2006 | 1695 | 0.010 |
Why?
|
Image Enhancement | 1 | 2009 | 2881 | 0.010 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 1999 | 378 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2024 | 64572 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2014 | 10175 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2012 | 3805 | 0.010 |
Why?
|
Genotype | 1 | 2010 | 12977 | 0.010 |
Why?
|
Logistic Models | 1 | 2010 | 13248 | 0.010 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1999 | 1128 | 0.010 |
Why?
|
Antigens, Viral | 1 | 1999 | 988 | 0.010 |
Why?
|
Risk Assessment | 1 | 2016 | 23974 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2011 | 22153 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12661 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2009 | 20077 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2006 | 12966 | 0.010 |
Why?
|
Mice | 1 | 1999 | 81368 | 0.000 |
Why?
|
Concepts
(222)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(43)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_